Slopak, I completely agree. The FDA is now an obvious obstacle but it is not the only one. If this little company is to succeed and be credible to investors, it will have to learn to operate with an independent board and chairman of the board. That is just one step in many that are necessary. Growing revenue and becoming profitable is another. Research and development of products that are comfortable and convenient to use is another. Expansion of applications and modalities of operation, uplisting to a higher exchange, establishing control over sales and marketing, the list goes on. Bioelectronics has a solid base of clinical studies and patents, but it is still an infant as a corporation and will have growing pains in its future.